YOUNGER patients get Zostavax to prevent shingles

May 2011

You'll see YOUNGER patients get Zostavax to prevent shingles.

Zostavax was initially approved for ages 60 and up...now the Public Health Agency of Canada recommends it for ages 50 and up.

Zostavax reduces the relative risk of shingles by about 70% for patients age 50 to 59...and by about 50% for patients 60 and up.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Diabetes choose between Byetta (exenatide) and Victoza (liraglutide) for type 2 diabetes
Neurology & Pain new opioid analgesic called Nucynta CR (new-SIN-tah)
Gastroenterology more kids should get ORAL ondansetron (Zofran, etc) for the stomach flu
Allergic Reactions true allergy to iodine is a medical myth
Psychiatry systemic corticosteroids can cause adverse CNS effects
Vaccines YOUNGER patients get Zostavax to prevent shingles
Women's Health when to use metformin or pioglitazone for polycystic ovary syndrome (PCOS)
Women's Health progesterone to prevent preterm births
Asthma new inhaler for asthma called Zenhale
Asthma children getting inhaled corticosteroids PRN for MILD persistent asthma
Oral Health warning about the use of OTC oral benzocaine gels or liquids (Anbesol Gel, Orajel, etc)
Lupus new IV monoclonal antibody for severe systemic lupus erythematosus (SLE), Benlysta (ben-LIST-a, belimumab)
Antithrombotics whether patients should stop anticoagulant or antiplatelet meds before dental procedures